Schistosoma mansoni
Jump to navigation
Jump to search
Epidemiology
- infection is acquired through freshwater contact, from which larvae infect humans via skin penetration.
- Nile river, Uganda, Africa
Pathology
- Schistosoma mansoni resides in mesenteric venules
- eggs migrate to liver, lung & CNS
- immunologic response to the antigens present during the maturation process of the schistosomal worm
Clinical manifestations
- diarrhea, hematochezia may occur
- hepatosplenomegaly & abdominal pain may occur
Laboratory
- Schistosoma mansoni serology
- ova & parasites in stool
- eggs are not shed in excreta until 2 months after initial infection
- shedding of eggs varies over time
- complete blood count (CBC)
- eosinophilia may be observed
Diagnostic procedures
Complications
- appendicitis
- intestinal stenosis
- protein-losing enteropathy
- periportal fibrosis, portal hypertension, variceal bleeding, &ascites
- pulmonary hypertension
Management
- praziquantel
- inactive against immature worms
- treatment 6-8 weeks after last exposure to contaminated water
- 40 mg/kg in 2 doses (same day)
- second course of treatment is indicated if symptoms persistent or if eosinophilia after treatment
More general terms
Additional terms
References
- ↑ Gleeson SE, Zhang X, Azar MM Recurrent Hematochezia in a Returning Traveler. JAMA. Published online March 5, 2021. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33666646 https://jamanetwork.com/journals/jama/fullarticle/2777393